Emilia Sif Asgrimsdottir
Overview
Explore the profile of Emilia Sif Asgrimsdottir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sif Asgrimsdottir E, Arenas E
Stem Cell Res
. 2024 Oct;
81:103523.
PMID: 39383604
Midbrain dopaminergic (mDA) neurons derived from human pluripotent stem cells (hPSCs) offer a promising cell source for cell replacement therapy in Parkinson's disease (PD). Single-cell RNA sequencing (scRNA-seq) of the...
2.
Nishimura K, Sif Asgrimsdottir E, Yang S, Arenas E
STAR Protoc
. 2023 Jun;
4(3):102355.
PMID: 37310863
Here, we present a protocol for the generation of functional midbrain dopaminergic (mDA) neurons from human embryonic stem cells (hESCs), which mimics the development of the human ventral midbrain. We...
3.
Nishimura K, Yang S, Lee K, Sif Asgrimsdottir E, Nikouei K, Paslawski W, et al.
Stem Cell Reports
. 2022 Nov;
18(1):337-353.
PMID: 36400027
Stem cell technologies provide new opportunities for modeling cells in health and disease and for regenerative medicine. In both cases, developmental knowledge and defining the molecular properties and quality of...
4.
Sif Asgrimsdottir E, Arenas E
Front Cell Dev Biol
. 2020 Aug;
8:463.
PMID: 32733875
Parkinson's disease (PD) is a progressive neurodegenerative disorder that predominantly affects dopaminergic (DA) neurons of the substantia nigra. Current treatment options for PD are symptomatic and typically involve the replacement...